Quick Answer
NeuroPace Inc reported Earnings Per Share Diluted of $0.66 (loss) per share for the year ending 2025.
- NeuroPace Inc showed an increase of +29.0% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from NeuroPace Inc's annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $33.32 (loss) per share | Q2 2020: $43.44 (loss) per share | Q3 2020: $19.26 (loss) per share | Q1 2021: $32.73 (loss) per share | Q2 2021: $0.48 (loss) per share | Q3 2021: $0.34 (loss) per share | Q1 2022: $0.47 (loss) per share | Q2 2022: $0.52 (loss) per share | Q3 2022: $0.48 (loss) per share | Q1 2023: $0.41 (loss) per share | Q2 2023: $0.36 (loss) per share | Q3 2023: $0.28 (loss) per share | Q1 2024: $0.32 (loss) per share | Q2 2024: $0.26 (loss) per share | Q3 2024: $0.19 (loss) per share | Q1 2025: $0.21 (loss) per share | Q2 2025: $0.26 (loss) per share | Q3 2025: $0.11 (loss) per share.
- Over the full 6 years of available data (2020 to 2025), NeuroPace Inc's Earnings Per Share Diluted has grown by 99.4%.
- Historical annual values: Fiscal year 2025: $0.66 (loss) per share | Fiscal year 2024: $0.93 (loss) per share | Fiscal year 2023: $1.27 (loss) per share | Fiscal year 2022: $1.91 (loss) per share | Fiscal year 2021: $2.17 (loss) per share | Fiscal year 2020: $117.85 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: